Southern Africa is rapidly positioning itself as a pivotal hub for biopharmaceutical manufacturing, aiming to enhance regional health security and reduce reliance on external markets. This strategic shift presents significant B2B trade opportunities for global suppliers and investors looking to engage with a burgeoning African healthcare sector.

Kenya's healthcare sector is experiencing significant growth, driven by increasing demand for quality medical services and infrastructure development. This expansion presents substantial opportunities for B2B suppliers of medical equipment, technology, and related services across East Africa. The nation's commitment to universal health coverage (UHC) and a burgeoning middle class are key catalysts, pushing for modern facilities and advanced medical solutions. International manufacturers and distributors are increasingly looking to Kenya as a strategic entry point into the wider East African market, seeking to meet the evolving needs of both public and private healthcare providers.

Zimbabwe has legalised cannabis cultivation and has withdrawn laws requiring sole state ownership for cannabis farming in an effort to encourage investment in cannabis cultivation for industrial and medicinal uses.

The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The value of Africa’s pharmaceutical industry jumped to $20.8 billion in 2013 from just $4.7 billion a decade earlier. That growth is continuing at a rapid pace and it is predicted that the market will be worth $40 billion to $65 billion by 2020. That’s good news for multinationals and pharmaceutical companies seeking new sources of growth as developed markets stagnate. It’s also good news for patients, who have gained access to medicines previously unavailable on the continent. 

The pharmaceuticals industry in Africa is one of the fastest growing sectors of business in Africa. The value of Africa’s pharmaceutical industry is expected to be worth $40 billion to $65 billion by 2020 from just $14.5 billion a decade earlier. This makes Africa a prime market for multinationals and pharmaceutical companies seeking new growth markets as traditional markets stagnate. The rapid growth of the pharmaceutical industry in Africa also augurs well for African patients, who have gained access to medicines previously unavailable in the African markets.

The pharmaceutical industry in Kenya is growing at a rapid pace and offers excellent opportunities for exporters and manufacturers to establish their products and services in the lucrative market for pharmaceuticals in East Africa. Kenya is currently the largest producer of pharmaceutical products in the Common Market for Eastern and Southern Africa (COMESA) region, supplying about 50% of the regions’ market.

Nigeria is one of the most promising and rapidly growing pharmaceutical markets in West Africa with more than 150 pharma formulation manufacturing facilities. The Nigerian pharma industry is growing at 13 % annually. The estimated market size is $1.8billion. In the ECOWAS (Economic Community of West African States) West Africa sub-region approximately 60% of drug manufacturing takes place in Nigeria, underlining the huge sub regional market.

The research team at Africa Business Pages has compiled a valuable database of pharmaceutical companies in Africa through painstaking work across more than 20 African countries. The result is the compilation of the first ever Africa Pharmaceutical Directory which lists more than 6,500 pharmaceutical companies in Africa. This database of pharmaceutical-related companies in Africa lists wholesalers of pharmaceuticals in Africa, pharmacies in Africa, pharmaceutical retailers in Africa, hospital suppliers in Africa, Pharmaceuticals Distributors, Clinics & Hospitals, Government Medical Clinics, Medical Institutes as well Manufacturers of Pharmaceuticals in Africa.